Identification and Study of Biomarkers from Novichok-Inhibited Butyrylcholinesterase in Human Plasma

Molecules. 2021 Jun 22;26(13):3810. doi: 10.3390/molecules26133810.

Abstract

To identify biomarkers of ethyl (1-(diethylamino)ethylidene)phosphoramidofluoridate (A234)- or methyl (1-(diethylamino)ethylidene)phosphoramidofluoridate (A232)-inhibited butyrylcholinesterase (BChE), we investigated nonapeptide adducts containing the active site serine, which plays a key role in enzyme activity, using LC-MS/HRMS. Biomarkers were acquired as expected, and they exhibited a significant amount of fragment ions from the inhibiting agent itself, in contrast to the MS2 spectra of conventional nerve agents. These biomarkers had a higher abundance of [M+2H]2+ ions than [M+H]+ ions, making doubly charged ions more suitable for trace analysis.

Keywords: LC-MS/MS; Novichok; chemical warfare agents; nerve agent.

MeSH terms

  • Biomarkers / blood
  • Butyrylcholinesterase / blood*
  • Cholinesterase Inhibitors / pharmacokinetics
  • Cholinesterase Inhibitors / toxicity
  • Humans
  • Nerve Agents* / pharmacokinetics
  • Nerve Agents* / toxicity
  • Organophosphates* / pharmacokinetics
  • Organophosphates* / toxicity
  • Plasma*

Substances

  • Biomarkers
  • Cholinesterase Inhibitors
  • Nerve Agents
  • Organophosphates
  • novichok
  • BCHE protein, human
  • Butyrylcholinesterase